• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

足月胎儿生长受限期待治疗与引产治疗新生儿发病率的比较:DIGITAT RCT 的亚组分析。

Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT.

机构信息

Bronovo Hospital, The Hague, The Netherlands.

出版信息

Am J Obstet Gynecol. 2012 Apr;206(4):344.e1-7. doi: 10.1016/j.ajog.2012.01.015. Epub 2012 Jan 13.

DOI:10.1016/j.ajog.2012.01.015
PMID:22342897
Abstract

OBJECTIVE

The Disproportionate Intrauterine Growth Intervention Trial at Term (DIGITAT) compared induction of labor and expectant management in suspected intrauterine growth restriction (IUGR) at term. In this subanalysis, we report neonatal morbidity between the policies based on the Morbidity Assessment Index for Newborns (MAIN).

STUDY DESIGN

We used data from the DIGITAT. For each neonate, we calculated the MAIN score, a validated outcome scale.

RESULTS

There were no differences in mean MAIN scores or in MAIN morbidity categories. We found that neonatal admissions are lower after 38 weeks' gestational age compared with 36 and 37 weeks in both groups.

CONCLUSION

The incidence of neonatal morbidity in IUGR at term is comparable and relatively mild either after induction or after an expectant policy. However, neonatal admissions are lower after 38 weeks of pregnancy, so if induction to preempt possible stillbirth is considered, it is reasonable to delay until 38 weeks, provided watchful monitoring.

摘要

目的

足月胎儿宫内生长受限干预试验(DIGITAT)比较了疑似宫内生长受限(IUGR)足月时引产与期待治疗的效果。在此子分析中,我们根据新生儿发病率评估指标(MAIN)报告了两种策略之间的新生儿发病率。

研究设计

我们使用了 DIGITAT 的数据。对于每个新生儿,我们计算了 MAIN 评分,这是一种经过验证的结局评分。

结果

两组新生儿 MAIN 评分的平均值或 MAIN 发病率类别均无差异。我们发现,两组中,与 36 周和 37 周相比,38 周时新生儿入院率较低。

结论

IUGR 足月时,无论采用引产还是期待治疗,新生儿发病率相当且相对较轻。然而,38 周后新生儿入院率较低,因此,如果考虑引产以预防可能的死产,在密切监测下,合理的做法是延迟至 38 周。

相似文献

1
Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT.足月胎儿生长受限期待治疗与引产治疗新生儿发病率的比较:DIGITAT RCT 的亚组分析。
Am J Obstet Gynecol. 2012 Apr;206(4):344.e1-7. doi: 10.1016/j.ajog.2012.01.015. Epub 2012 Jan 13.
2
Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial).比较足月胎儿生长受限引产与期待治疗的经济学分析(DIGITAT 试验)。
Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):358-63. doi: 10.1016/j.ejogrb.2013.07.017. Epub 2013 Aug 1.
3
Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial.哪些足月宫内生长受限胎儿从早期分娩诱导中获益?DIGITAT 随机试验的二次分析。
Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172:20-5. doi: 10.1016/j.ejogrb.2013.10.014. Epub 2013 Oct 16.
4
Intrauterine growth restriction at term: induction or spontaneous labour? Disproportionate intrauterine growth intervention trial at term (DIGITAT): a pilot study.足月时的宫内生长受限:引产还是自然分娩?足月时不成比例的宫内生长干预试验(DIGITAT):一项试点研究。
Eur J Obstet Gynecol Reprod Biol. 2006 Mar 1;125(1):54-8. doi: 10.1016/j.ejogrb.2005.06.018. Epub 2005 Jul 27.
5
Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial.宫内生长受限婴儿引产与期待治疗对 2 岁时(神经)发育和行为结局的影响:DIGITAT 试验的长期结局。
Am J Obstet Gynecol. 2012 May;206(5):406.e1-7. doi: 10.1016/j.ajog.2012.02.003. Epub 2012 Mar 22.
6
Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT).足月胎儿生长受限的引产与期待治疗的随机等效性试验(DIGITAT)
BMJ. 2010 Dec 21;341:c7087. doi: 10.1136/bmj.c7087.
7
A risk of waiting: the weekly incidence of hypertensive disorders and associated maternal and neonatal morbidity in low-risk term pregnancies.等待的风险:低危足月妊娠中高血压疾病及其相关母婴发病率的周发生率。
Am J Obstet Gynecol. 2016 Mar;214(3):389.e1-389.e12. doi: 10.1016/j.ajog.2015.09.095. Epub 2015 Oct 9.
8
Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT.足月时不成比例的宫内生长干预试验:DIGITAT。
BMC Pregnancy Childbirth. 2007 Jul 10;7:12. doi: 10.1186/1471-2393-7-12.
9
Intrauterine growth restriction increases morbidity and mortality among premature neonates.宫内生长受限会增加早产新生儿的发病率和死亡率。
Am J Obstet Gynecol. 2004 Aug;191(2):481-7. doi: 10.1016/j.ajog.2004.01.036.
10
Expectant management of pregnancies complicated by fetal growth restriction without any evidence of placental dysfunction at term: Comparison with routine labor induction.足月时无胎盘功能障碍证据的胎儿生长受限合并妊娠的期待管理:与常规引产的比较。
J Obstet Gynaecol Res. 2018 Jan;44(1):93-101. doi: 10.1111/jog.13461. Epub 2017 Sep 11.

引用本文的文献

1
Fetal and Neonatal Outcomes in Fetuses with an Estimated Fetal Weight Percentile of 10-20 in the Early Third Trimester: A Retrospective Cohort Study.孕晚期胎儿估计体重百分位数为10-20的胎儿及新生儿结局:一项回顾性队列研究
Diagnostics (Basel). 2025 Sep 5;15(17):2251. doi: 10.3390/diagnostics15172251.
2
Artificial Intelligence in Fetal Growth Restriction Management: A Narrative Review.人工智能在胎儿生长受限管理中的应用:一篇叙述性综述。
J Clin Ultrasound. 2025 May;53(4):825-831. doi: 10.1002/jcu.23918. Epub 2025 Jan 29.
3
Neonatal Outcomes of Infants Diagnosed with Fetal Growth Restriction during Late Pregnancy versus after Birth.
妊娠晚期与出生后诊断为胎儿生长受限的婴儿的新生儿结局
J Clin Med. 2024 Jun 27;13(13):3753. doi: 10.3390/jcm13133753.
4
FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.国际妇产科联盟(FIGO)胎儿生长倡议:胎儿生长受限筛查、诊断及管理的最佳实践建议
Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1):3-57. doi: 10.1002/ijgo.13522.
5
Postnatal Catch-Up Growth After Suspected Fetal Growth Restriction at Term.足月时疑似胎儿生长受限后的出生后追赶生长
Front Endocrinol (Lausanne). 2019 Jun 20;10:274. doi: 10.3389/fendo.2019.00274. eCollection 2019.
6
More Maternal Vascular Malperfusion and Chorioamnionitis in Placentas After Expectant Management vs. Immediate Delivery in Fetal Growth Restriction at (Near) Term: A Further Analysis of the DIGITAT Trial.期待治疗与即刻分娩对(近)足月胎儿生长受限胎盘母体血管灌注不良及绒毛膜羊膜炎影响的比较:DIGITAT试验的进一步分析
Front Endocrinol (Lausanne). 2019 Apr 24;10:238. doi: 10.3389/fendo.2019.00238. eCollection 2019.
7
Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).宫内生长受限。德国妇产科学会指南(S2k级别,德国医学专业协会注册编号015/080,2016年10月)
Geburtshilfe Frauenheilkd. 2017 Nov;77(11):1157-1173. doi: 10.1055/s-0043-118908. Epub 2017 Nov 27.
8
Using perinatal morbidity scoring tools as a primary study outcome.采用围产儿发病率评分工具作为主要研究结局。
J Epidemiol Community Health. 2017 Nov;71(11):1090-1093. doi: 10.1136/jech-2017-209419.
9
Suspected Fetal Growth Restriction at 37 Weeks: A Comparison of Doppler and Placental Pathology.37周时疑似胎儿生长受限:多普勒检查与胎盘病理检查的比较
Biomed Res Int. 2017;2017:3723879. doi: 10.1155/2017/3723879. Epub 2017 Mar 20.
10
Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.计划早期分娩与对足月疑似胎儿窘迫的婴儿进行期待管理以改善结局。
Cochrane Database Syst Rev. 2015 Nov 24;2015(11):CD009433. doi: 10.1002/14651858.CD009433.pub2.